2021;25(2):331-323
CASE REPORT

doi: 10.5935/1518-0557.20200078

Sertoli Cells Only Syndrome - Case Report

Ana Bartmann1

1Universidade de Ribeirão Preto - UNAERP - Ribeirão Preto - SP

Received June 07, 2020
Accepted December 10, 2020

Corresponding Author:
Ana K. Bartmann
Universidade de Ribeirão Preto - UNAERP
Ribeirão Preto - SP - Brazil
Email: anabartmann@uol.com.br

CONFLICT OF INTEREST
The author declare that they have no conflict of interest to disclose

ABSTRACT
Exclusive Sertoli Cell Syndrome (ESCS) is a rare condition that has male infertility as its main consequence. It is one of the most serious forms of non-obstructive azoospermia, with a poor reproductive prognosis. In some cases, however, such as the type II of the syndrome, sperm can be recovered through testicular puncture and subsequent ICSI, with a 13% success rate. This article aims to report the case of an azoospermic 35-year-old patient, with no other significant changes in complementary exams. After percutaneous puncture of the epididymis and biopsy with no sperm, we diagnosed ESCS, and indicated IVF with donor semen.

Keywords: Exclusive Sertoli Cell Syndrome, azoospermia, IVF

INTRODUCTION
Exclusive Sertoli Cell Syndrome, also called germ cell aplasia or Del Castillo Syndrome, is a rare condition that results in male infertility (Gat et al., 2010; Behre et al., 2015). In general, the patient is male with normal external genitalia, well-developed secondary sexual characteristics and azoospermia (Hanmayyagari et al., 2015). It is one of the most serious forms of non-obstructive azoospermia, and may be associated with other clinical manifestations in some cases (Kavoussi et al., 2019; Paduch et al., 2019). However, the main complaint that makes the couple seek medical advice is the unsuccessful attempt at pregnancy (Kim et al., 2015).
It is characterized by the exclusive presence of Sertoli cells (without germ cells) in seminiferous tubules, making spermatogenesis impossible (Paulis et al., 2017). Leydig’s interstitial cells are present and produce testosterone normally. It can be primary, characterized by a reduction in growth factors GDNF, FGF8 and BMP4 - that at low levels do not induce replication and the stimulus for the differentiation of spermatogenic stem cells into spermatogonia or, secondary, as Klinefelter’s Syndrome, exposure to toxins or chemicals, viruses, radiotherapy, trauma and varicocele (Gat et al., 2019; Behre et al., 2015; Kavoussi et al., 2019; Paduch et al., 2019; Stouffs et al., 2016; Nistal et al., 1990).
Sertoli cells secrete anti-Mullerian hormone (AMH), which promotes the regression of Müller’s ducts as the male fetus develops (Behre et al., 2015; Kim et al., 2015; Anniballo et al., 2011). They also secrete inhibin and activin, which regulate FSH secretion by the hypothalamus (Kim et al., 2015). Activin increases the FSH levels needed for semen production, while inhibin helps maintain testicular homeostasis (Kim et al., 2015). In general, the complaint is infertility (Jain & Halder, 2012). The physical examination is not enlightening, and, in some cases, there may be testicular atrophy (10-20 mL in volume) or bilateral varicocele, without other important findings (Gat et al., 2010; Kavoussi et al., 2019; Matsumoto & Bremner, 2016). There are no signs of feminization, such as gynecomastia, and all male characteristics are preserved - Hanmayyagari et al., 2015.
In clinical investigation, there is a high FSH level and preserved testosterone levels (Behre et al., 2015; Hanmayyagari et al., 2015). AMH and inhibin B concentrations are decreased, and the luteinizing hormone (LH) may be normal or elevated (Hanmayyagari et al., 2015). In the semen, we find azoospermia (in syndrome’s type I), and we can rarely find spermatogenic spots (in syndrome’s type II) (Behre et al., 2015; Paulis et al., 2017; Abofoul-Azab et al., 2019). The karyotype is male, with no changes; however, microdeletions may occur on the Y chromosome (Stouffs et al., 2016; Jain & Halder, 2012). All of these findings and changes are suggestive of Exclusive Sertoli Cell Syndrome, but the final diagnosis is made with testicular biopsy revealing a complete absence of germ cells and seminiferous tubules covered by Sertoli cells only (Gat et al., 2010; Matsumoto & Bremner, 2016).
The reproductive prognosis of affected patients is quite poor, as there is no way to treat the condition itself (Hanmayyagari et al., 2015; Kavoussi et al., 2019; Paulis et al., 2017). In most cases, donor’s semen is used when the couple is interested in pregnancy (Hanmayyagari et al., 2015). Although sperm can be recovered in type II of the syndrome during testicular puncture (testicular sperm extraction TESE), current research suggests that only 13% of men were successful in ICSI procedures (Hanmayyagari et al., 2015; Paulis et al., 2017; Stouffs et al., 2016). In the case of obtaining an embryo by ICSI, pre-implantation genetic diagnosis is indicated to rule out possible chromosomal malformations and printing disorders related to the fertilization process, such as Angelman and Prader-Willi Syndromes (Fertilitypedia, 2020; Pan et al., 2018). Moreover, some studies report that such patients have an increased risk of testicular cancer. Thus, routine clinical assessments in men with SCOS are important (Kavoussi et al., 2019; Paduch et al., 2019).

OBJECTIVE
To report the case of a patient with Sertoli Cell Only Syndrome.

MATERIALS AND METHODS
We evaluated the medical records of the couple and a ran a bibliographic review in the Pubmed and LILACS databases, using the terms “Sertoli cell only syndrome”, “azoospermia”, “infertility”, “Testicular Disorders”. The review was carried out between September and December 2019.

CASE REPORT
A.K.G., male, 35 years old, came with his wife to the Human Reproduction Center/Ana Bartmann Clinic of the Ribeirão Preto University (UNAERP) due to primary infertility. At the time of the consultation, they brought several spermograms, all of them with azoospermia.
Azoospermia was investigated: FSH, LH, TSH, total and free testosterone, karyotype and testicular ultrasound. With the exams, we diagnosed obstructive azoospermia and indicated percutaneous epididymis puncture (PESA) (Table 1). The patient accepted more invasive procedures if no viable sperm would be found during the procedure.

 

Table 1
Table 1. Results of the tests performed

 

On the same day, after the woman’s oocyte retrieval, the patient’s testicular puncture was performed. As no sperm was obtained after multiple attempts, we chose to perform testicular biopsy by microsurgery. The anatomopathological result of the testicular biopsy was testicles with germ-cell aplasia. Hypotrophic seminiferous tubules with foci of sclerosis represented 10% of the samples and there was complete absence of germ cells.
We indicated fertilization of oocytes the captured with donor semen.

DISCUSSION
In this report, we discuss the case of a patient with Sertoli cell-only syndrome, a rare and irreversible cause of male infertility. We diagnosed infertility by analyzing the semen that revealed azoospermia. However, the syndrome’s etiology is only defined through testicular biopsy in which normal Sertoli cells can be found, but without germ cells.
The importance of early correction of other testicular pathologies, such as cysts, varicocele or hydrocele, is highlighted, so as not to impair male reproductive function and consequent secondary infertility.
Regarding treatment, those cases are difficult to manage, since there is no effective and available therapy for the syndrome. Current possibilities include ICSI, in cases where some sperm are found in the testicular puncture (type II syndrome), and semen donation as in the case described.
Unfortunately, in our case, the patient reported great difficulty in accepting donor semen. The oocytes were frozen and the couple is undergoing psychological counseling.

REFERENCES
Abofoul-Azab M, Lunenfeld E, Levitas E, Zeadna A, Younis JS, Bar-Ami S, Huleihel M. Identification of premeiotic, meiotic, and postmeiotic cells in testicular biopsies without sperm from sertoli cell-only syndrome patients. Int J Mol Sci. 2019;20:470. PMID: 30678285 DOI: 10.3390/ijms20030470
Medline Crossref

Anniballo R, Brehm R, Steger K. Recognising the Sertoli-cell-only (SCO) syndrome: a case study. Andrologia.2011;43:78-83. PMID: 21219389 DOI: 10.1111/j.1439-0272.2009.01030.x
Medline Crossref

Behre HM, Bergmann M, Simoni M, Tüttelmann F. Primary testicular failure. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, Grossman A, Hershman JM, Hofland HJ, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Purnell J, Singer F, Stratakis CA, Trence DL, Wilson DP, eds. Endotext. South Dartmouth: MDText.com, Inc.; 2015.

Fertilitypedia [Site in the Internet]. Sertoli cell-only syndrome: the absence of any developmental stage of sperm cell in the testes. Prague: Fertilitypedia; 2020. Available at: https://fertilitypedia.org/edu/diagnoses/sertoli-cell-only-syndrome. Accessed: 11/03/2020.

Gat Y, Gornish M, Perlow A, Chakraborty J, Levinger U, Ben-Shlomo I, Pasqualotto F. Azoospermia and Sertoli-cell-only syndrome: hypoxia in the sperm production site due to impairment in venous drainage of male reproductive system. Andrologia. 2010;42:314-21. PMID: 20860630 DOI: 10.1111/j.1439-0272.2010.01047.x
Medline Crossref

Hanmayyagari B, Guntaka M, Srinagesh. A rare case of male infertility: Sertoli only syndrome. CHRISMED J Health Res. 2015;2:64-7. DOI: 10.4103/2348-3334.149350
Crossref

Jain M, Halder A. Sertoli cell only syndrome: Status of sertoli cell maturation and function. Indian J Endocrinol Metab. 2012;16:S512-3. PMID: 23565483 DOI: 10.4103/2230-8210.104154
Medline Crossref

Kavoussi PK, Hunn C, Gilkey MS, Chen SH, Kavoussi KM, Wininger JD, Kavoussi SK. Sertoli cell only syndrome induced by a varicocele. Transl Androl Urol. 2019;8:405-8. PMID: 31555565 DOI: 10.21037/tau.2019.06.17
Medline Crossref

Kim ED, Mobley JD, Stewart AF, Moss J. Sertoli-Cell-Only Syndrome. Medscape Reference; 2015. Available at: https://emedicine.medscape.com/article/437884-overview

Matsumoto AM, Bremner WJ. Testicular disorders. In: Melmed S, Larsen PR, Polonsky KS, Kronenberg HM, eds. Williams textbook of endocrinology. Amsterdam: Elsevier; 2016. p. 694-784.

Nistal M, Jimenez F, Paniagua R. Sertoli cell types in the Sertoli-cell-only syndrome: relationships between Sertoli cell morphology and aetiology. Histopathology. 1990;16:173-80. PMID: 2182507 DOI: 10.1111/j.1365-2559.1990.tb01086.x
Medline Crossref

Paduch DA, Hilz S, Grimson A, Schlegel PN, Jedlicka AE, Wright WW. Aberrant gene expression by Sertoli cells in infertile men with Sertoli cell-only syndrome. PLoS One. 2019;14:e0216586. PMID: 31071133 DOI: 10.1371/journal.pone.0216586
Medline Crossref

Pan MM, Hockenberry MS, Kirby EW, Lipshultz LI. Male infertility diagnosis and treatment in the era of in vitro fertilization and intracytoplasmic sperm injection. Med Clin North Am. 2018;102:337-47. PMID: 29406062 DOI: 10.1016/j.mcna.2017.10.008
Medline Crossref

Paulis G, Paulis L, Romano G, Concas C, Di Sarno M, Pagano R, Di Filippo A, Di Petrillo ML. Pregnancy and live birth after follicle-stimulating hormone treatment for an infertile couple including a male affected by Sertoli cell-only syndrome. Res Rep Urol. 2017;9:203-8. PMID: 29134181 DOI: 10.2147/RRU.S148071
Medline Crossref

Stouffs K, Gheldof A, Tournaye H, Vandermaelen D, Bonduelle M, Lissens W, Seneca S. Sertoli cell-only syndrome: behind the genetic scenes. Biomed Res Int. 2016;2016:6191307. PMID: 26925412 DOI: 10.1155/2016/6191307
Medline Crossref